Vancouver, Canada

Nicholas Erho

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator in Machine Learning and Cancer Research - Nicholas Erho

Introduction

Nicholas Erho, an accomplished inventor based in Vancouver, CA, has made significant contributions to the fields of machine learning and cancer research. With a portfolio of seven patents, Erho is dedicated to developing innovative methodologies that enhance medical diagnostics and treatment.

Latest Patents

Among Nicholas Erho's latest patents is a groundbreaking system and method for preprocessing target data and generating predictions using a machine learning model. This invention allows for the generation of likelihood scores related to various medical conditions by utilizing sophisticated machine learning techniques. The process involves deriving pre-computed vectors from a training dataset to generate processed data from target samples. This method can effectively normalize target data, enhancing the predictive accuracy of medical assessments.

Another notable patent focuses on subtyping prostate cancer to predict response to hormone therapy. This invention provides various methods, systems, and kits for the diagnosis, prognosis, and determination of cancer progression. The approach includes the use of biomarkers that define significant subgroups of prostate cancer, along with clinically useful classifiers to distinguish between different prostate cancer subtypes. These innovations not only empower medical practitioners with tools for expression-based analysis but also propose treatment methods based on molecular subtyping.

Career Highlights

Throughout his career, Nicholas Erho has worked with prestigious organizations, including Decipher Biosciences, Inc. and the Mayo Foundation for Medical Education and Research. His unique blend of expertise in both artificial intelligence and oncology has poised him as a leader in developing cutting-edge solutions for cancer diagnosis and treatment.

Collaborations

Erho has collaborated with notable professionals in the field, including Elai Davicioni and Ismael A Vergara Correa. These partnerships reflect the innovative spirit and teamwork necessary to advance research and create impactful inventions in healthcare.

Conclusion

Nicholas Erho's contributions through his patents illustrate his commitment to innovation in the medical field. By leveraging machine learning to enhance cancer diagnosis and treatment, he continues to pave the way for more effective healthcare solutions, impacting countless lives in the process.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…